Protection of Spanish Ibex (Capra pyrenaica) against Bluetongue virus serotypes 1 and 8 in a subclinical experimental infection.
Many wild ruminants such as Spanish ibex (Capra pyrenaica) are susceptible to Bluetongue virus (BTV) infection, which causes disease mainly in domestic sheep and cattle. Outbreaks involving either BTV serotypes 1 (BTV-1) and 8 (BTV-8) are currently challenging Europe. Inclusion of wildlife vaccination among BTV control measures should be considered in certain species. In the present study, four out of fifteen seronegative Spanish ibexes were immunized with a single dose of inactivated vaccine against BTV-1, four against BTV-8 and seven ibexes were non vaccinated controls. Seven ibexes (four vaccinated and three controls) were inoculated with each BTV serotype. Antibody and IFN-gamma responses were evaluated until 28 days after inoculation (dpi). The vaccinated ibexes showed significant (P<0.05) neutralizing antibody levels after vaccination compared to non vaccinated ibexes. The non vaccinated ibexes remained seronegative until challenge and showed neutralizing antibodies from 7 dpi. BTV RNA was detected in the blood of non vaccinated ibexes from 2 to the end of the study (28 dpi) and in target tissue samples obtained at necropsy (8 and 28 dpi). BTV-1 was successfully isolated on cell culture from blood and target tissues of non vaccinated ibexes. Clinical signs were unapparent and no gross lesions were found at necropsy. Our results show for the first time that Spanish ibex is susceptible and asymptomatic to BTV infection and also that a single dose of vaccine prevents viraemia against BTV-1 and BTV-8 replication.
Centre de Recerca en Sanitat Animal, UAB-IRTA, Campus de la Universitat Autònoma de Barcelona, Barcelona, Spain. cristina.lorca@cresa.uab.cat
Cristina
C
Lorca-Oró
Joan
J
Pujols
Ignacio
I
García-Bocanegra
Gregorio
G
Mentaberre
José Enrique
JE
Granados
David
D
Solanes
Paulino
P
Fandos
Iván
I
Galindo
Mariano
M
Domingo
Santiago
S
Lavín
Jorge Ramón
JR
López-Olvera
D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D001819:Bluetongue / Q000097:blood / Q000473:pathology / Q000517:prevention & control*; D001820:Bluetongue virus / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity*; D004198:Disease Susceptibility; D005260:Female; D006041:Goats; D006403:Hematologic Tests; D007371:Interferon-gamma / Q000097:blood; D007963:Leukocytes, Mononuclear / Q000821:virology; D008297:Male; D012367:RNA, Viral / Q000032:analysis / Q000302:isolation & purification; D012756:Sheep; D014765:Viral Vaccines / Q000276:immunology*
D000914:Antibodies, Viral; D012367:RNA, Viral; D014765:Viral Vaccines; D007371:Interferon-gamma